Top 5 Life Sciences Stocks To Own For 2014

Small cap robotic stock Adept Technology (NASDAQ: ADEP) has put in a very good performance this month verses its immediate peer�iRobot Corporation (NASDAQ: IRBT) as well as against medical robotic stocks like MAKO Surgical (NASDAQ: MAKO), Accuray Incorporated (NASDAQ: ARAY) and Hansen Medical, Inc (NASDAQ: HNSN). I should also mention that we have recently added Adept Technology to our SmallCap Network Elite Opportunity (SCN EO) portfolio (we are up 9% since last week) because we feel robotics is an improving sector as companies aim to reduce overhead and improve efficiencies through machine to machine (M2M) automation.

What is Adept Technology?

Founded in 1983, small cap Adept Technology is the largest US based manufacturer of industrial robots. More specifically, Adept Technology�� product lines include industrial robots, configurable linear modules, machine controllers for robot mechanisms and other flexible automation equipment, machine vision, and systems and applications software. In addition, the company�provides specialized, cost-effective robotics systems and services to high-growth markets including Packaged Goods, Life Sciences, Disk Drive/Electronics and Semiconductor/Solar plus to�traditional industrial markets�which include�machine tool automation and automotive components.

Best Valued Companies To Own For 2015: Altra Holdings Inc.(AIMC)

Altra Holdings, Inc., through its subsidiary, Altra Industrial Motion, Inc., designs, produces, and markets a range of mechanical power transmission and motion control products worldwide. The company provides industrial clutches and brakes for elevators, forklifts, lawn mowers, oil well draw works, punch presses, and conveyors; open and enclosed gearing products for conveyors, ethanol mixers, packaging machinery, and metal processing equipment; and engineered couplings for extruders, turbines, steel strip mills, and pumps. It also offers engineered bearing assemblies for cargo rollers, seat storage systems, and conveyors; power transmission components for conveyors, lawn mowers, and machine tools; and engineered belted drives for pumps, sand and gravel conveyors, and industrial fans. The company sells its products under the Warner Electric, Boston Gear, TB Wood?s, Kilian, Nuttall Gear, Ameridrives, Wichita Clutch, Formsprag Clutch, Bibby Transmissions, Stieber, Matrix, In ertia Dynamics, Twiflex, Industrial Clutch, Huco Dynatork, Marland Clutch, Delroyd, Warner Linear, and Bauer Gear Motor brands through its sales force, industrial distributors, and independent sales representatives. It serves aerospace, energy, food processing, general industrial, material handling, mining, petrochemical, transportation, and turf and garden markets. The company is headquartered in Braintree, Massachusetts.

Advisors' Opinion:

• [By Brian Pacampara]

  What: Shares of power transmission products maker Altra Holdings (NASDAQ: AIMC  ) plummeted 17% today after its quarterly results and outlook disappointed Wall Street.�

• [By Seth Jayson]

  When judging a company's prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it's booking in the accounting fantasy world we call "earnings." This is one of the first metrics I check when I'm hunting for the market's best stocks. Today, we'll see how it applies to Altra Holdings (Nasdaq: AIMC  ) .

Top 5 Life Sciences Stocks To Own For 2014: Powershares Golden Dragon (PGJ)

PowerShares Golden Dragon Halter USX China Portfolio is based on the Halter USX China Index. The Index is comprised of the United States listed securities of companies, which derive a majority of their revenue from the People's Republic of China. The fund was incepted on December 9, 2004.

The sectors covered by the investment include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, materials, telecommunications and utilities. PowerShares Capital Management LLC provides investment management to the Fund.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  PowerShares Golden Dragon China Portfolio (NYSE: PGJ) has a position in more than 70 companies, and its holdings are all U.S.-listed companies that generate most of their revenue in China. For that reason, Alibaba is the perfect candidate to join PGJ's holdings once it starts trading on the New York Stock Exchange.

• [By Robert Martin]

  With that in mind, here are four of the best emerging market ETF picks: A China ETF, an India ETF, and two other ETFs that track broad indices like the MSCI Emerging Markets Index.

  PowerShares Gold Dragon Halter USX China Portfolio (PGJ)

  Expense Ratio: 0.7%

Top 5 Life Sciences Stocks To Own For 2014: Pacific Biosciences of California Inc.(PACB)

Pacific Biosciences of California, Inc., a development stage company, develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a technology platform that enables single molecule, real-time (SMRT) for the detection of biological processes. It primarily focuses on the deoxyribonucleic acid sequencing market. The company?s product includes the PacBio RS, a sequencing platform, which consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits. The company?s customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

Advisors' Opinion:

• [By Alex Planes]

  However, Fool biotech expert Brian Orelli points out one big caveat: Once sequencing companies make these tests accessible, margins may collapse beyond the ability of volume sales to make up the difference. At least Illumina (and Life Tech) are in the driver's seat on margins, as it's unlikely that lesser-funded sequencing competitors Affymetrix (NASDAQ: AFFX  ) and Pacific Biosciences (NASDAQ: PACB  ) can muster the resources to push out sequencing at cost-effective scale before their peers.

• [By Geoff Gannon]

  1. Steel Excel (SXCL)
  2. FormFactor (FORM)
  3. Imation (IMN)
  4. Tuesday Morning (TUES)
  5. Pacific Biosciences (PACB)
  6. Maxygen (MAXY)
  7. Westell (WSTL)
  8. Volt Information Sciences (VISI)
  9. Yasheng Group (YHGG)

Top 5 Life Sciences Stocks To Own For 2014: Fomento Economico Mexicano SAB de CV (FOMC)

Fomento Economico Mexicano SAB de CV (FEMSA) is a Mexico-based holding company engaged in the beverages industry. Through its subsidiary Coca-Cola FEMSA SAB de CV, the Company is active in the production and distribution of a variety of non-alcoholic beverages, bottled water and still beverages such brands as Coca-Cola, Fanta, Sprite, Powerade, Delaware Punch and other trademark beverages of The Coca-Cola Company in Mexico. Through FEMSA Comercio SA de CV, it operates the OXXO convenience-store chain in Latin America. The Company operates in a number of Latinamerican countries and in Philippines. Advisors' Opinion:

• [By CanadianValue]

  Former Philadelphia Fed President Edward Boehne elegantly described the approach at a Federal Open Market Committee (FOMC) meeting in late 1989:

  ��ow, sooner or later, we will have a recession. I don�� think anybody around the table wants a recession or is seeking one, but sooner or later we will have one. If in that recession we took advantage of the anti-inflation (impetus) and we got inflation down from 4 1/2 percent to 3 percent, and then in the next expansion we were able to keep inflation from accelerating, sooner or later there will be another recession out there. And so, if we could bring inflation down from cycle to cycle just as we let it build up from cycle to cycle, that would be considerable progress over what we��e done in other periods in history.��/p>

• [By Canadian Value]

  Also interesting is that the duration of rising rate environments is distinctly shorter after 1982. The average duration declines to 14 months from 40 months prior to 1982. A possible explanation could be changes in the monetary mechanism influencing interest rates. In 1982, the Federal Open Market Committee (FOMC) first referenced a targeted federal funds rate.7